Princeton Capital Management LLC Axogen, Inc. Transaction History

Princeton Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$17.09 - $38.25 $85,450 - $191,250	-5,000 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$34.05 - $55.9 $170,250 - $279,500	5,000 New	5,000 $184,000
Q2 2018 Aug 02, 2018	SELL	$36.15 - $52.5 $180,750 - $262,500	-5,000 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$24.4 - $40.25 $122,000 - $201,250	5,000 New	5,000 $183,000

162

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $661M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Princeton Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Princeton Capital Management LLC with notifications on news.